INNV

InnovAge Holding Corp

Add to Watchlist

Advanced Chart

3.840

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

3.835

Open

3.835

VWAP

Vol

1.13K

Mkt Cap

518.45M

Low

3.835

Amount

EV/EBITDA(TTM)

23.22

Total Shares

135.99M

523.40M

EV/OCF(TTM)

20.34

P/S(TTM)

0.63

InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q1

FY2025Q4

232.55M

+11.27%

228.60M

+11.44%

219.80M

+10.23%

Estimates Revision

The market is revising Upward the revenue expectations for InnovAge Holding Corp. (INNV) for FY2025, with the revenue forecasts being adjusted by 0.55% over the past three months. During the same period, the stock price has changed by 25.90%.

Revenue Estimates for FY2025

Revise Upward

+0.55%

In Past 3 Month

Stock Price

Go Up

+25.90%

In Past 3 Month

1 Analyst Rating

4.17% Upside

Wall Street analysts forecast INNV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

4.17% Upside

Current: 3.840

Low

4.00

Averages

4.00

High

4.00

4.17% Upside

Current: 3.840

Low

4.00

Averages

4.00

High

4.00

JP Morgan

Lisa Gill

Hold

Sell

Downgrades

2024-12-17

Reason

JP Morgan

Lisa Gill

Price Target

2024-12-17

Downgrades

Hold

Sell

Reason

JPMorgan downgraded InnovAge to Underweight from Neutral with a $5 price target. The company operates within a sensitive market and is subject to higher scrutiny from both state and federal regulators, which has presented an extended headwind to growth prospects over the past three years, the analyst tells investors in a research note. The firm cites lingering headwinds to InnovAge's long-term growth prospects presented by regulatory scrutiny from both state and federal regulators for the downgrade.

Keybanc

Matthew Gillmor

Hold

Initiates

n/a

2024-10-11

Reason

Keybanc

Matthew Gillmor

Price Target

n/a

2024-10-11

Initiates

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for InnovAge Holding Corp (INNV.O) is -143.28, compared to its 5-year average forward P/E of -53.67. For a more detailed relative valuation and DCF analysis to assess InnovAge Holding Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-53.67

Current PE

-143.28

Overvalued PE

1129.83

Undervalued PE

-1237.17

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-5.06

Current EV/EBITDA

12.43

Overvalued EV/EBITDA

197.73

Undervalued EV/EBITDA

-207.84

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.38

Current PS

0.56

Overvalued PS

2.46

Undervalued PS

0.29